Months into a shortage of Ozempic — a popular drug for its off-label weight-loss use — diabetes patients are rationing the product, The Wall Street Journal reported Feb. 22.
Read the full post on Becker's Hospital Review - Healthcare News
Patients ration Ozempic amid low supply
